{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:56:35Z","timestamp":1761504995005,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K16601"],"award-info":[{"award-number":["20K16601"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.yebeh.2022.109070","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T06:28:53Z","timestamp":1672727333000},"page":"109070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Immediate and 6-month seizure outcomes following first and second SARS-CoV2 mRNA vaccinations: A multicenter study with a nationwide survey"],"prefix":"10.1016","volume":"139","author":[{"given":"Megumi","family":"Nonaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Neshige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetada","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Takebayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Agari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2022.109070_b0005","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healthpol.2021.05.016","article-title":"A comparative study of public health and social measures of COVID-19 advocated in different countries","volume":"125","author":"Wang","year":"2021","journal-title":"Health Policy"},{"key":"10.1016\/j.yebeh.2022.109070_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00296-020-04744-9","article-title":"COVID-19 pandemic in Japan","volume":"41","author":"Amengual","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.yebeh.2022.109070_b0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 mRNA COVID-19 Vaccine: First Approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2022.109070_b0020","first-page":"1663","article-title":"COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines","volume":"25","author":"Meo","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.yebeh.2022.109070_b0025","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s40264-021-01104-9","article-title":"Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report","volume":"44","author":"Iguchi","year":"2021","journal-title":"Drug Saf"},{"key":"10.1016\/j.yebeh.2022.109070_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107238","article-title":"Epilepsy self-management during a pandemic: Experiences of people with epilepsy","volume":"111","author":"Miller","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.109070_b0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.yebeh.2022.109070_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108160","article-title":"COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center","volume":"122","author":"von Wrede","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.109070_b0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/epi.17138","article-title":"COVID-19 vaccine take-up rate and safety in adults with epilepsy: Data from a multicenter study in China","volume":"63","author":"Lu","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.109070_b0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.seizure.2021.08.001","article-title":"Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study","volume":"92","author":"Massoud","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.109070_b0055","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-022-06100-0","article-title":"Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience","author":"Romozzi","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2022.109070_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108808","article-title":"Observational retrospective analysis of vaccination against SARS-CoV-2 and seizures: VACCI-COVID registry","volume":"134","author":"Martinez-Fernandez","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.109070_b0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/INF.0000000000002553","article-title":"Adverse Events Following Immunization Among Children With Epilepsy: A Self-Controlled Case Series","volume":"39","author":"Top","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.yebeh.2022.109070_b0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12887-018-1112-0","article-title":"Risk of seizures after immunization in children with epilepsy: a risk interval analysis","volume":"18","author":"Top","year":"2018","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.yebeh.2022.109070_b0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.109070_b0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2022.109070_b0085","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2022.109070_b0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2022.109070_b0095","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2022.109070_b0100","first-page":"789","article-title":"Helping the Public Understand Adverse Events Associated With COVID-19 Vaccinations: Lessons Learned From Functional Neurological Disorder","volume":"78","author":"Kim","year":"2021","journal-title":"J Am Med AssocNeurol"},{"key":"10.1016\/j.yebeh.2022.109070_b0105","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mdc3.13267","article-title":"Tics and TikTok: Functional Tics Spread Through Social Media","volume":"8","author":"Hull","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.yebeh.2022.109070_b0110","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/archneur.64.11.1595","article-title":"Epilepsy: accuracy of patient seizure counts","volume":"64","author":"Hoppe","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2022.109070_b0115","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1016\/j.clinph.2021.08.010","article-title":"Nationwide online EEG education during coronavirus disease 2019 pandemic","volume":"132","author":"Neshige","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2022.109070_b0120","doi-asserted-by":"crossref","unstructured":"Team CC-R, Administration FaD. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14\u201323, 2020. MMWR Morb Mortal Wkly Rep 2021;70:46\u201351. https:\/\/doi.org\/10.15585\/mmwr.mm7002e1.","DOI":"10.15585\/mmwr.mm7002e1"},{"key":"10.1016\/j.yebeh.2022.109070_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117607","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review","volume":"428","author":"Sharifian-Dorche","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2022.109070_b0130","first-page":"e2140364","article-title":"Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination","volume":"4","author":"Beatty","year":"2021","journal-title":"J Am Med AssocNetw Open"},{"key":"10.1016\/j.yebeh.2022.109070_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108258","article-title":"The impact of SARS-CoV-2 vaccination in Dravet syndrome: A UK survey","volume":"124","author":"Clayton","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.109070_b0140","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.2147\/IDR.S315727","article-title":"Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action","volume":"14","author":"Mascellino","year":"2021","journal-title":"Efficacy Safety Infect Drug Resist"},{"key":"10.1016\/j.yebeh.2022.109070_b0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.yebeh.2022.109070_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102741","article-title":"Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence","volume":"125","author":"Garrido","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.yebeh.2022.109070_b0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17925\/ENR.2013.08.01.31","article-title":"Autoimmune Encephalitis","volume":"8","author":"Leypoldt","year":"2013","journal-title":"Eur Neurol Rev"},{"key":"10.1016\/j.yebeh.2022.109070_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.743110","article-title":"Attitudes to Being Vaccinated Against COVID-19: A Survey of People With Epilepsy in China","volume":"12","author":"Qiao","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2022.109070_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108822","article-title":"Should patients with epilepsy be vaccinated against coronavirus disease 2019? A systematic review and meta-analysis","volume":"134","author":"Lin","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2022.109070_b0170","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.3906\/sag-2110-153","article-title":"Epidemiology of COVID-19: What changed in one year?","volume":"51","author":"Bulut","year":"2021","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.yebeh.2022.109070_b0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/idr14010016","article-title":"Registry Systems for COVID-19 Vaccines and Rate of Acceptability for Vaccination Before and After Availability of Vaccines in 12 Countries: A Narrative Review","volume":"14","author":"Papagiannis","year":"2022","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.yebeh.2022.109070_b0180","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2022.109070_b0185","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.26143","article-title":"Guillain-Barr\u00e9 Syndrome following ChAdOx1-S\/nCoV-19 Vaccine","volume":"90","author":"Maramattom","year":"2021","journal-title":"Ann Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022005194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505022005194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:49:32Z","timestamp":1761504572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505022005194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":37,"alternative-id":["S1525505022005194"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.109070","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immediate and 6-month seizure outcomes following first and second SARS-CoV2 mRNA vaccinations: A multicenter study with a nationwide survey","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.109070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109070"}}